Statin-induced myopathy is rare
Danish Medical Journal · 2026-08 · 1-6
DOI: 10.61409/a02260103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Danish Medical Journal, 2026-08. Verfasst von Philip Lindblad Thorsen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Aalborg University Hospital. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscular Diseases.
Abstract (Originalsprache)
INTRODUCTION. Statin-induced myopathy (SIM) is a rare but serious complication of statin therapy. Immune-mediated necrotising myopathy linked to anti-3-hydroxy-3-methylglutaryl (HMG)-CoA reductase (anti-HMGCR) antibodies requires timely recognition. This study examined the occurrence and documentation of SIM and the use of antibody testing in a regional cohort. METHODS. This was a register-based study using data from regional registries and medical records (2020-2024). Patients with creatine kinase (CK) > 10 × the upper limit of normal while receiving statin therapy were identified, characterised and compared, with a special focus on anti-HMGCR antibody testing and documentation of statin intolerance. RESULTS. Among 1,003 patients, 32 (3.2%) were considered to have SIM. These patients had a higher median CK than other patients (7,800 versus 3,783 U/l; p < 0.001). High-intensity therapy was more frequent in SIM (72% versus 52%; p = 0.02), with a prevalence ratio of 2.34 (95% CI: 1.09-5.00). Anti-HMGCR testing was performed in 56% of SIM cases; antibody-positive patients had lower CK and higher eGFR. Documentation of statin intolerance in the electronic record CAVE field (adverse drug reaction) was present in only 59%. CONCLUSIONS. Severe SIM is uncommon (4.3 cases/100,000 patient-years), but documentation and diagnostic testing are inconsistent. Systematic recording and broader antibody testing may improve patient safety. FUNDING. None. TRIAL REGISTRATION. Not relevant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Aalborg University Hospital.
- Department of Clinical Pharmacology, Aarhus University Hospital.
- Medical Diagnostic Centre, Regional Hospital Central Jutland.
- Institute of Clinical Medicine, Aarhus University.
- University Research Clinic for Innovative Patient Pathways, Regional Hospital Central Jutland.
- Department of Molecular Medicine, Aarhus University Hospital, Denmark.
Zitieren
APA
Thorsen, P. L., Okkels, A. S., Trolle, C., & Breining, P. (2026). Statin-induced myopathy is rare. Danish Medical Journal, 1-6. https://doi.org/10.61409/a02260103
Vancouver
Thorsen PL, Okkels AS, Trolle C, Breining P. Statin-induced myopathy is rare. Danish Medical Journal. 2026:1-6. doi:10.61409/a02260103
BibTeX
@article{Thorsen2026,
author = {Thorsen, Philip Lindblad and Okkels, Anna Sophie and Trolle, Christian and Breining, Peter},
title = {Statin-induced myopathy is rare},
journal = {Danish Medical Journal},
year = {2026},
pages = {1--6},
doi = {10.61409/a02260103}
}
EUVIMED